Drug for curing asthma
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 辽宁省中医药研究院
- Publication Date
- 2009-10-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating asthma. Background technique
[0002] Bronchial asthma (hereinafter referred to as asthma) is an allergic inflammatory disease characterized by airway hyperresponsiveness (AHR) involving various cells, cytokines and inflammatory mediators. Due to the intricate pathogenesis of asthma, it is still not fully understood. At present, western medicine studies on the pathogenesis of asthma mainly focus on the theory of airway inflammation, the theory of immunity and allergy, the mechanism of airway nerve regulation, and the genetic mechanism. Asthma can occur at any age, has an obvious family history, has the characteristics of recurrent attacks, and has a long course of disease. If it is not controlled in time, it may cause serious complications and even cause death. Moreover, its morbidity and mortality are increasing day by day. It is one of the ...